about
Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imagingA case of apical ballooning cardiomyopathy associated with duloxetineLoss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarctionEffects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.Relation of carotid plaque with natural IgM antibodies in patients with systemic lupus erythematosusChoroidal thickness in patients with coronary artery diseaseImpact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trialA severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry.Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.Role of transesophageal echocardiography in the evaluation of patients with stroke.Substernal epicardial echocardiography: review of a new technique.Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates.Comparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial)Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT).Adverse Trends in Ischemic Heart Disease Mortality among Young New Yorkers, Particularly Young Black WomenCoronary intervention for persistent occlusion after myocardial infarctionEffect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment.The value of core lab stress echocardiography interpretations: observations from the ISCHEMIA Trial.Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT)Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease.Ambient Particulate Matter Air Pollution Exposure and Mortality in the NIH-AARP Diet and Health Cohort.Paradoxical septal motion after cardiac surgery: a review of 3,292 cases.Long-term outcomes after a strategy of percutaneous coronary intervention of the infarct-related artery with drug-eluting stents or bare metal stents vs medical therapy alone in the Occluded Artery Trial (OAT).Cardiogenic shock: current concepts and improving outcomes.Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT)Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA.Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosusCardiovascular disease in young women: a population at risk.Myocardial infarction without obstructive coronary artery disease.Mechanisms of myocardial infarction without obstructive coronary artery disease.Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.Quality and Equitable Health Care Gaps for Women: Attributions to Sex Differences in Cardiovascular Medicine.Sex and race are associated with the absence of epicardial coronary artery obstructive disease at angiography in patients with acute coronary syndromes.Diabetes and ischemic heart disease death in people age 25-54: a multiple-cause-of-death analysis based on over 400 000 deaths from 1990 to 2008 in New York City.Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery.The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study.Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines).
P50
Q26827495-7DB22C29-4C53-4E17-A6C4-AF299BC95F73Q28289705-022BE8D7-D220-49AA-923E-6BD9C9BFC0AFQ30429019-44527943-A86C-4E40-99B1-C9ED4572B444Q30434062-718DA470-6662-49EF-ADF2-646B223742A6Q33792693-A856B4C2-44D6-4DE4-A403-E4038DA5AB02Q33799781-C64A9A5B-2FB8-4221-A123-011E2353D619Q33817248-1C3FAD2C-1626-4B32-AB9A-D40C840CAA34Q33978681-F8ED9005-FC3B-4FC1-9C1D-C0687BC373AEQ34497058-F9514E9B-EC91-4FC4-BD55-9E50F3D63237Q34549223-11C4173B-63C7-467E-A6C8-DC64069F4F57Q35213836-7ED0D00A-B099-4DF3-B954-6AD4576D9936Q35580071-CD8CE2BD-FDED-4C4C-84DE-5BC997988205Q35607236-52FF0A6F-AFF6-43B8-904E-C82FDDA64279Q35771737-2E4E9FB5-F603-4277-B225-4D5E5D9FA7DBQ35784799-9D4CF7DB-A8A1-4F53-BFE1-F5D0E8B81EF0Q35840858-4612786D-4BC6-4985-9EEE-47FDE5A8AA3DQ35925039-D39C9CBB-DBF4-42CE-B470-D56CF0E9A3ECQ36016654-6825EF2D-BD2A-46A9-A9B0-7EBA19FEB8F9Q36227525-A899A5E3-4E72-45C3-9835-F2AB250D0905Q36383558-FBD56786-1BD4-454A-B2C4-B695C063C852Q36455475-796489F4-245C-49F0-98D2-087C1F397EFCQ36747886-0C6471B5-572A-40E7-8F1F-846A2FAB15E0Q36793467-E768182B-25E6-4518-AA58-92C84D7B46F3Q37028182-32AD6023-1484-4D04-82A9-0B0C730822A0Q37074525-533EED4F-28EF-4535-A4C1-FDE1B9DAE6B5Q37077213-20ADBBF9-EB1A-40E5-816B-1A0C510F4C76Q37082952-2CA489EF-83A9-4DB0-95FB-2AF832CF595CQ37227540-94D2EA9A-CF35-4E0A-84D2-389B0D387FD9Q37637815-26E4CB02-32E9-4FDB-84E8-EAEC947F436CQ37658803-2461E4CA-1600-480F-B211-577F5B1DA675Q37834209-CDA94131-CC29-40C4-813C-EDDABA50E8D9Q38039892-E618698E-430A-4BEC-AD17-C62C4B26C9F1Q38180262-E7879F4E-4A51-4233-BBBF-441D2925333CQ38398337-DBD23601-6BC9-40CD-A483-F3A5F9D07346Q39433375-12EF6953-7BC2-4BBF-B80C-4C9689D13A29Q39947537-E45750ED-E1F4-42BD-9BD1-FD521E140B5EQ41463751-C94BA6E0-A0F8-4C1F-AD7F-379E3B115724Q43271244-5C7E2D9C-2E23-40E2-B6FA-9200D26A58ADQ44924573-B6400803-792E-4F90-BB66-7C3ADE482597Q47300249-C813736B-D8C8-4805-87A4-80F5358B3BBA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Harmony R Reynolds
@ast
Harmony R Reynolds
@en
Harmony R Reynolds
@es
Harmony R Reynolds
@nl
Harmony R Reynolds
@sl
type
label
Harmony R Reynolds
@ast
Harmony R Reynolds
@en
Harmony R Reynolds
@es
Harmony R Reynolds
@nl
Harmony R Reynolds
@sl
prefLabel
Harmony R Reynolds
@ast
Harmony R Reynolds
@en
Harmony R Reynolds
@es
Harmony R Reynolds
@nl
Harmony R Reynolds
@sl
P106
P21
P31
P496
0000-0003-0284-0655